CHICAGO , Oct. 6, 2022 /PRNewswire/ -- The OTC Braces and Supports Market is valued at an estimated USD 942 million in 2022 and is projected to reach USD 1,286 million by 2027, at a CAGR of 6.4%, according to a new report by MarketsandMarkets™. Market growth is driven by the rising technological advancements in OTC braces and supports, increasing orthopedic disorders and the growing awareness of preventive diagnosis in developing countries. Emerging economies such as China , Japan , and India are providing lucrative opportunities for the players operating in the OTC braces and supports market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=113271585
Browse in-depth TOC on "OTC Braces and Supports Market" 137 – Tables 42 – Figures 274 – Pages
The knee braces and supports segment had the major share of the OTC braces and supports Market, by product, in 2021" Based on product, the OTC braces and supports market is divided into knee, ankle; back, hip, & spine; foot walkers and orthoses; hand & wrist; shoulder; elbow; and facial braces and supports. Due to the numerous benefits these products offer, including medial and lateral support, reduced knee rotation, limited injury in motion, and as protection from risk of injury following surgery, the knee braces and supports segment is anticipated to have the highest growth during forecast period.
In 2021, preventive care segment accounted for the largest share in the market, by application" Based on the application, the OTC braces and supports market is segmented into preventive care, ligament injury, osteoarthritis, compression therapy, and other applications. The preventive care segment is expected to command the largest share of the market in 2022. The large share of this segment can be attributed to increasing public participation in sports-related activities and rising off-the-shelf usage of bracing products for preventive care & ambulatory procedures.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=113271585
In 2021, pharmacies and retailers segment accounted for the largest share in the market, by distribution channel" Based on the distribution channel, the OTC braces and supports market is classified into pharmacies & retailers, e-commerce platforms, orthopedic clinics and hospitals. Pharmacies and retailers are expected to be the largest distribution channel segment in the OTC braces and supports market. The growth of this market segment is majorly driven by the wide availability of orthopedic bracing products through retailers & pharmacies, rising adoption of off-the-shelf products for sprain & ligament injuries in major countries (due to easy access), and the growing public awareness about the clinical benefits of orthopedic braces in preventive care.
"North America accounted for the largest share of the otc braces and supports market " The global otc braces and supports market is segmented into five major regions namely, North America , Europe , the Asia Pacific , Latin America , and the Middle East & Africa . North America held the biggest market share of the OTC braces and supports market in 2021. Market growth is attributed to the development and commercialization of novel orthopedic braces & support products, favorable reimbursements & insurance coverage for major orthopedic bracing procedures, supportive government regulations for product commercialization, and significant sports participation. The major players operating in this market are 3M (US), DJO Global (US), Essity (Sweden ), Zimmer Biomet Holdings, Inc (US), Ottobock Healthcare (Germany ), Össur HF (Iceland ), medi GmbH (Germany ), DeRoyal Industries Inc (US), Bauerfeind AG (Germany ), Bird & Cronin (US), Breg Inc. (US), Thuasne (France ), TruLife Group (Ireland ), Alcare (Japan ), Prim SA (Spain ), and Foundation Wellness (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=113271585
Browse Adjacent Market: Medical Devices Market Research Reports & Consulting
Related Reports: Compression Therapy Market by Technique (Static, Dynamic), Product (Garments (Stockings, Bandages, Wraps), Ortho Braces, Pump), Application (Varicose Vein, DVT, Lymphedema, Leg Ulcer), Distribution (Clinics, Pharmacies, E-Comm) Global Forecast (2022 - 2026)
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/otc-orthopedic-braces-market.asp Visit Our Website: https://www.marketsandmarkets.com/ Content Source: https://www.marketsandmarkets.com/PressReleases/otc-orthopedic-braces.asp
Logo - https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/otc-braces--supports-market-worth-1-286-million-by-2027--exclusive-report-by-marketsandmarkets-301642552.html
Inflation and higher interest rates could be here to stay. BofA says changing demographics, deglobalization, and underinvestment in energy production have created a new “regime” for the global economy.
The U.S. stock market took an unusual swing after Thursday’s inflation report. “Shortly after the open, the S&P 500 index had dropped nearly 4% from its pre-market highs before staging an epic rally of over 5%,” Bespoke Investment Group said in a note Friday. “Even in this ‘all or nothing’ type of market environment, reversals of that magnitude are rare.”
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. And at a 2009 shareholder meeting, Buffett noted that the first best thing you can do to protect against inflation is to invest in yourself and your skills: “If you’re the best teacher, if you’re the best surgeon, if you’re the best lawyer, you will get your share of the national economic pie regardless of the value of whatever the currency may be,” he said.
Investors seemingly can’t stop trying to pick a stock market bottom, no matter how bad the news—and it continues to backfire. Consider: This past Thursday, September’s consumer inflation report came in much hotter than expected, with the core CPI hitting a 40-year high. The initial response was exactly what you’d expect—the traded down as much as 2.4%—but then it started rallying…and rallying.
Investors were surprised by the big rally in the stock market on Thursday, but Friday brought another dose of reality and disappointment. After having posted monumental gains despite high readings on inflation, the Nasdaq Composite (NASDAQINDEX: ^IXIC) closed at its worst level of the year, and the S&P 500 (SNPINDEX: ^GSPC) and Dow Jones Industrial Average (DJINDICES: ^DJI) gave up most of their advances from earlier in the week. One of the biggest stock stories of the past several years has been Tesla (NASDAQ: TSLA).
Being patient doesn't always pay off.
Everyone is hoping the market might be bottoming and by the recent actions of Bank of America clients, some evidently think the lows must be in sight. Last week, BofA customers splashed out $6.1 billion on US stocks, in what amounted to the third largest inflow since 2008. While the bank has stated it is not as confident the bottom is quite so close, it’s not hard to see why investors feel the time is right to lean into equities. The widespread losses have left scores of beaten-down stocks looki
These diversified natural-resource giants have solid balance sheets, earnings, and dividends. All that they need is a rebound in commodity prices.
Nikola (NKLA) founder Trevor Milton was found guilty of three counts of criminal fraud on Friday in a case accusing him of spreading lies about the electric truck startup for his own personal benefit.
A look at the shareholders of Advanced Micro Devices, Inc. ( NASDAQ:AMD ) can tell us which group is most powerful. The...
Last month, the Federal Reserve implemented its fifth straight interest rate hike this year, and its third consecutive hike at 75 basis points, bringing its key funds rate up to the 3% to 3.25% range. The move showed that the central bank is deadly serious about taking on the stubbornly high inflation that has been plaguing the economy since the middle of 2021. The Fed’s turn toward an aggressive anti-inflationary policy may not be hard enough, however, as the September data, released this morni
Goldman is staying long and strong Tesla. Here's why.
Making investments pay out for the long term is the true challenge in today’s market environment. The series of headwinds piling up – from persistently high inflation to rising interest rates to slowing demand to bureaucratic bloat – are rising to hurricane force, and renewing investors’ attention to defensive stocks. It’s only logical. The classic defensive stock, the dividend payer, ensures an income stream no matter how the markets move, and if the yield is high enough, these stocks can also
In the midst of a bear market, with rising interest rates and the threat of a prolonged recession in the air, real estate investment trust (REIT) stocks have endured tremendous price declines. Given this, it isn’t easy to find REITs that could see dividend increases soon. Two questions come to mind. Why would a company raise its dividend when the yield is already increasing with each drop in price? And how do you find REITs with the dividend well-covered by funds from operations (FFO) and with s
Dividends are the bread and butter of income investors. You don't need to sell your assets or spend hours every day managing your accounts. Instead, dividend stocks simply generate income on their own. Putting together a portfolio that generates at least … Continue reading → The post How to Make $1,000 a Month in Dividends appeared first on SmartAsset Blog.
Shares of electric vehicle (EV) manufacturer Rivian (NASDAQ: RIVN) sank in Friday morning trading. At that time, the tech-heavy Nasdaq Composite was down by 2.3%. A number of factors were working against Rivian's shares.
Shares of Tesla (NASDAQ: TSLA) were initially trading higher at the market open on Friday before market traders turned their attention back to the economy, which sent most stocks down today. As of 12:42 p.m. ET, the stock was trading down 5.4%, while the Nasdaq Composite was down 2.3%. The sell-off comes after another analyst issued a positive note on Tesla ahead of next week's third-quarter earnings report.
Cathie Wood’s flagship exchange-traded fund finally closed below its early pandemic lows on Friday, after slipping below that line in intraday trading twice this week. The $7.1 billion ARK Innovation ETF (ticker: ARKK) closed at $$33.99 on Friday, crossing the 2020 closing low of $34.69 it marked in March that year when the overall markets plunged. The Innovation fund, established in 2014, includes Unity Software (U), Zoom Video Communications (ZM) and Roblox (RBLX) as its top holdings.
The Senior Citizen’s League says there ‘may be no COLA payable in 2024.'